PT - JOURNAL ARTICLE AU - Rocio Rivas AU - Edward Dratz AU - Thomas Wagner AU - Gary Secor AU - Amanda Leckband AU - David C. Sands TI - Rapid Screening Methods of Potato Cultivars for Low Glycemic Trait AID - 10.1101/2021.08.09.455724 DP - 2021 Jan 01 TA - bioRxiv PG - 2021.08.09.455724 4099 - http://biorxiv.org/content/early/2021/08/09/2021.08.09.455724.short 4100 - http://biorxiv.org/content/early/2021/08/09/2021.08.09.455724.full AB - Potatoes are a dietary staple consumed by a significant portion of the world, providing valuable carbohydrates and vitamins with minimal fat. Most commercially produced potatoes have a high content of highly branched amylopectin starch, which generally results in a high glycemic index (GI). Consumption of foods with high levels of amylopectin elicit a rapid spike in blood glucose levels, which is undesirable for individuals who are pre-diabetic, diabetic, or obese. Some cultivars of potatoes with lower amylopectin levels have previously been identified and are commercially available in niche markets in some countries but are relatively unavailable in the United States and Latin America. Among Native communities in North America and in the high Andes countries of South America, some foods that include certain potato cultivars, may have been used to help people mitigate what is now defined as the effects of blood sugar and obesity. These cultivars are not widely available on a global market. This study utilizes three independent analyses of potato starch: microscopic examination of granule structure, water absorption, and spectrophotometry of iodine complexes to identify potato cultivars with low amylopectin that are thought to have low GI potential. Differences among cultivars tested were detected by all three types of analyses. Of the 60 potato cultivars evaluated the most promising are Huckleberry Gold, Muru, Multa, Green Mountain, and an October Blue x Colorado Rose cross. Further work is necessary to document the ability of these low amylopectin cultivars to reduce blood glucose spike levels in human subjects.Competing Interest StatementThe authors have declared that no competing interests exist.